Uniform Language for Misdemeanor Traffic Offense

Colorado House Bill 1297 passed the Senate on April 6, 2026, establishing uniform statutory language for referencing misdemeanor traffic offenses. The bill, sponsored by a bipartisan group of legislators, passed the House 62-0 and received unanimous committee approval in both chambers. The legislation is primarily a definitional and terminological update affecting how courts and law enforcement classify and document certain traffic-related offenses.

Consumer Price Index Calculation Methodology

Colorado Governor signed HB1364 establishing the methodology for calculating the Consumer Price Index for the 2025 calendar year. The bill was introduced and referred to the House Appropriations Committee on April 2, 2026. This legislation affects fiscal calculations including tax bracket adjustments, public assistance eligibility thresholds, and government contractor compensation.

Repeal Decarbonization Tax Credits Administration Fund

Colorado Governor signed HB1362 into law on April 2, 2026, repealing the decarbonization tax credits administration cash fund. The bill was sponsored by bipartisan legislators including Representatives Sirota, Taggart, and Brown, and referred to the Appropriations Committee. This action eliminates the state fund used to administer decarbonization tax credit programs.

Technical Changes to Energy and Carbon Management Statutes

The Colorado General Assembly passed HB26-1303, making technical changes to energy and carbon management statutes. The bill passed the House 62-0 on March 16, 2026 and received unanimous approval in Senate committees before being signed into law. The legislation represents cleanup amendments to existing state energy regulations.

Correction of Military Children Compact Citation

Colorado HB26-1294 corrects an incorrect statutory citation within the definition of "active duty" for purposes of the Interstate Compact on Educational Opportunity for Military Children. The bill passed both chambers unanimously with no amendments and was referred to the Senate Committee of the Whole on consent calendar.

Child Welfare Subsidy Percentage Reduction

Colorado HB1373 reduces monthly subsidy reimbursement percentages for child welfare services provider contracts. The bill was signed by Governor on April 2, 2026, and includes a reduced appropriation for affected programs. Child welfare service providers in Colorado should prepare for decreased reimbursement rates under new contracts.

Repeals Medicaid Reimbursement for Equine Therapy

Colorado Governor signed HB1365 into law on April 2, 2026, eliminating Medicaid reimbursement for therapy using equine movement. The bill, sponsored by bipartisan legislators, also reduces the associated state appropriation. Healthcare providers offering equine therapy to Medicaid patients will no longer receive state reimbursement for these services.

Somerset Therapeutics Dexamethasone Injection Class II Recall

The FDA issued a Class II recall for Somerset Therapeutics LLC's Dexamethasone Sodium Phosphate Injection (100mg/10mL, 10x10mL vials) after stability testing at product expiry (24 months) revealed out-of-specification impurity levels. The affected impurities are Dexamethasone Sodium Phosphate EP Impurity G and dexamethasone formate. The recall is ongoing and affects nationwide distribution in the USA.

Teva Pharmaceuticals Octreotide Acetate Class II Sterility Recall

The FDA announced a Class II recall of Teva Pharmaceuticals' Octreotide Acetate for Injectable Suspension 10mg single-dose vials due to lack of sterility assurance. Quality system deficiencies were identified at the contract manufacturer Pharmathen International S.A. in Greece during a routine FDA inspection. The recall affects products distributed nationwide in the USA and is currently ongoing.

CUROSURF Sterility Recall - Chiesi USA

FDA announced Class II recall D-0402-2026 for CUROSURF (poractant alfa) 240mg Intratracheal Suspension by Chiesi USA, Inc. The recall was initiated due to lack of assurance of sterility. The affected product (NDC 10122-510-03) was distributed nationwide within the United States, and the recall is currently ongoing.